The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

The average short interest in the S&P 500 Health Care Index Sector (XLV) dipped slightly in July to 1.95% from 1.96% in June.

Enphase Energy (ENPH) retained its spot as the most shorted S&P 500 (SP500) stock as a percentage of float in July, followed ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

Mixed options sentiment in Moderna (MRNA), with shares down 9c near $26.80. Options volume relatively light with 20k contracts traded and calls ...

Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...

Moderna’s second quarter results were met with a negative market reaction, as investors focused on both a sharp decline in ...

Moderna may offer substantial upside, but it's essential to consider the associated risks. Since hitting their peak in late ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

RFK Jr. canceled nearly $500 million in mRNA vaccine research funding. Plus, the latest climate news, from flooding in Alaska ...

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...